Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia

Robert Chiesa1, Christos Georgiadis1, Farhatullah Syed1

  • 1From Great Ormond Street Hospital for Children NHS Trust (R.C., G.O., T.B., J.C., S.A., R.T., K.G., D.O., A.V., W.Q.) and the UCL Great Ormond Street Institute of Child Health (C.G., F.S., H.Z., A.E., S.A.G., R.P., A.K., W.Q.) - both in London.

Summary

Base editing precisely converts DNA nucleotides, enabling gene inactivation without breaks. This CRISPR-based approach generated effective chimeric antigen receptor T cells for treating relapsed leukemia in children.

Related Concept Videos